Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3403306
Max Phase: Preclinical
Molecular Formula: C35H57FN6O7
Molecular Weight: 692.87
Molecule Type: Small molecule
Associated Items:
ID: ALA3403306
Max Phase: Preclinical
Molecular Formula: C35H57FN6O7
Molecular Weight: 692.87
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CCN(CC)C(=O)[C@H](Cc1ccc(F)cc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H](N)COC(=O)[C@H](CC(C)C)NC(C)=O)C(C)C
Standard InChI: InChI=1S/C35H57FN6O7/c1-10-42(11-2)34(47)28(18-24-12-14-25(36)15-13-24)40-32(45)27(16-20(3)4)39-33(46)30(22(7)8)41-31(44)26(37)19-49-35(48)29(17-21(5)6)38-23(9)43/h12-15,20-22,26-30H,10-11,16-19,37H2,1-9H3,(H,38,43)(H,39,46)(H,40,45)(H,41,44)/t26-,27-,28-,29-,30-/m0/s1
Standard InChI Key: BUECTLKWYDAFQV-IIZANFQQSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 692.87 | Molecular Weight (Monoisotopic): 692.4273 | AlogP: 1.81 | #Rotatable Bonds: 20 |
Polar Surface Area: 189.03 | Molecular Species: NEUTRAL | HBA: 8 | HBD: 5 |
#RO5 Violations: 1 | HBA (Lipinski): 13 | HBD (Lipinski): 6 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 11.73 | CX Basic pKa: 7.22 | CX LogP: 2.22 | CX LogD: 2.00 |
Aromatic Rings: 1 | Heavy Atoms: 49 | QED Weighted: 0.13 | Np Likeness Score: -0.33 |
1. Zhen XL, Yin WH, Tian X, Ma ZJ, Fan SM, Han JR, Liu S.. (2015) Synthesis and biological evaluation of open-chain analogs of cyclic peptides as inhibitors of cellular Shp2 activity., 23 (10): [PMID:25865131] [10.1016/j.bmc.2015.03.035] |
Source(1):